ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Chronic Myelomonocytic Leukemia
Hematologic Cancer

Acute Myeloid Leukemia (AML) trials near Orlando, FL, USA:

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Fludarabine

Phase 3

PedAL BCU, LLC

Orlando, Florida, United States and 85 other locations

which contains populations of CD8+ T cells targeting multiple leukemia associated antigen peptides in patients with Acute Myeloid...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)
Biological: Infusion of NEXI-001 T Cells

Phase 1, Phase 2

NexImmune

Orlando, Florida, United States and 4 other locations

VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...

Enrolling
Leukemia, Myeloid, Acute
Drug: Venetoclax (VEN)
Drug: Azacitidine (AZA)

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Orlando, Florida, United States and 180 other locations

). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....

Enrolling
Acute Myeloid Leukemia
Drug: Tagraxofusp
Drug: Azacitidine

Phase 2

Stemline Therapeutics
Stemline Therapeutics

Orlando, Florida, United States and 32 other locations

combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...

Enrolling
Leukemia
Drug: Quizartinib
Drug: Placebo

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Kissimmee, Florida, United States and 277 other locations

drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to vene...

Enrolling
Leukemia, Myeloid, Acute
Drug: Azacitidine
Drug: Venetoclax

Phase 2

OncoVerity

Orlando, Florida, United States and 30 other locations

with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...

Enrolling
Acute Myeloid Leukemias
Drug: SNDX-5613
Drug: Chemotherapy Regimen

Phase 1

Syndax Pharmaceuticals
Syndax Pharmaceuticals

Orlando, Florida, United States and 39 other locations

A treatment cycle is 28 days for Cycle 1 and Cycle 2. Tagraxofusp will be administered at 12 mcg/kg IV over 15 minutes (-5 or +15 minutes) daily for...

Enrolling
Acute Myeloid Leukemia
Drug: Tagraxofusp (Cycles 1-2)
Drug: Tagraxofusp (Cycles 3-12)

Phase 2

Joshua Zeidner

Orlando, Florida, United States and 6 other locations

Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior in...

Enrolling
Leukemia, Myeloid, Acute
Drug: Cytarabine
Drug: Etoposide

Phase 3

Delta-Fly Pharma

Orlando, Florida, United States and 38 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems